Growth Metrics

GeneDx Holdings (WGS) Total Non-Current Liabilities: 2020-2025

Historic Total Non-Current Liabilities for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $197.4 million.

  • GeneDx Holdings' Total Non-Current Liabilities rose 3.45% to $197.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $197.4 million, marking a year-over-year increase of 3.45%. This contributed to the annual value of $168.6 million for FY2024, which is 4.20% down from last year.
  • As of Q3 2025, GeneDx Holdings' Total Non-Current Liabilities stood at $197.4 million, which was up 7.59% from $183.5 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Total Non-Current Liabilities high stood at $385.7 million for Q2 2021, and its period low was $140.4 million during Q3 2023.
  • For the 3-year period, GeneDx Holdings' Total Non-Current Liabilities averaged around $176.4 million, with its median value being $182.4 million (2024).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 136.98% in 2021, then tumbled by 54.95% in 2022.
  • Over the past 5 years, GeneDx Holdings' Total Non-Current Liabilities (Quarterly) stood at $144.1 million in 2021, then soared by 47.98% to $213.2 million in 2022, then dropped by 17.45% to $176.0 million in 2023, then declined by 4.20% to $168.6 million in 2024, then climbed by 3.45% to $197.4 million in 2025.
  • Its Total Non-Current Liabilities was $197.4 million in Q3 2025, compared to $183.5 million in Q2 2025 and $182.4 million in Q1 2025.